Event
FDA Medical Device User Fee Reauthorization and What It Means for Neurosurgery
FDA Medical Device User Fee Reauthorization and What It Means for Neurosurgery
October 20 @ 8:00 pm - 9:00 pm
Virtual Event
Event Description:
Join the AANS/CNS Washington Committee Drugs & Devices Subcommittee for a webinar examining the FDA’s Medical Device User Fee Amendments (MDUFA) and the impact of the upcoming reauthorization on neurosurgery.
Join the AANS/CNS Washington Committee Drugs & Devices Subcommittee for a webinar examining the FDA’s Medical Device User Fee Amendments (MDUFA) and the impact of the upcoming reauthorization on neurosurgery.
This session will provide an overview of how MDUFA is funded, how it supports medical device review, and what to expect from the next reauthorization cycle. Experts from the FDA, medical device industry, and clinical community will discuss how the program influences device development and review, with a focus on technologies neurosurgeons help develop and use.
Moderator:
Joshua M. Rosenow, MD
Chair, Drugs & Devices Subcommittee
Joshua M. Rosenow, MD
Chair, Drugs & Devices Subcommittee
Featured Speakers:
• Kathryn Capanna, MBA, Associate Director, Office of Strategic Partnerships and Technology Innovation, U.S. Food and Drug Administration
• Cory N. Criss, MD, Chief Operating Officer, Midwest Pediatric Device Consortium
• David McMullen, MD, Head of Medical Affairs, Neuralink
• Kathryn Capanna, MBA, Associate Director, Office of Strategic Partnerships and Technology Innovation, U.S. Food and Drug Administration
• Cory N. Criss, MD, Chief Operating Officer, Midwest Pediatric Device Consortium
• David McMullen, MD, Head of Medical Affairs, Neuralink
